Navigation Links
Instrumentation Laboratory Named Top of Class by Respiratory Care Managers
Date:9/12/2007

-- Based on Excellent QC, Customer Service and Reliability --

LEXINGTON, Mass., Sept. 12 /PRNewswire/ -- Instrumentation Laboratory (IL) today announced that it has been awarded the 2007 Top of Class Award, in the Blood Gas category, by readers of Advance for Managers of Respiratory Care Newsmagazine. Reasons readers selected IL for this award include: excellent quality control, dependable customer service and instrument reliability. Further, IL's GEM(R) Premier(TM) 3000 critical care analyzer was recognized as one of the readers' most valuable products.

The GEM Premier 3000 measures blood gas, electrolytes, metabolites and hematocrit in critical care hospital patients. These tests are often performed by respiratory therapists and overseen by pulmonologists and medical directors of respiratory care, department managers and supervisors. Advance is a leading monthly publication targeting over 20,000 such professionals.

"We are truly honored to be recognized by our customers with this award, and we couldn't agree more with the reasons they cited. Excellent quality control underlines the value of iQM(R), our state-of-the-art automated quality management system for our GEM Premier 3000 and new GEM Premier 4000 analyzers," said Ramon Benet, Vice President, Worldwide Marketing and US Sales and Service. "And our mission every day is to provide reliable instruments and excellent customer service so that our customers can focus on patient care, not on instruments."

Instrumentation Laboratory (http://www.ilus.com), founded in 1959, is a worldwide developer, manufacturer and distributor of in vitro diagnostic instruments, related reagents and controls for use primarily in hospitals and independent clinical laboratories. The company's product lines include critical care systems, hemostasis systems and information management systems. IL's GEM product offerings, part of the critical care line, inclu
'/>"/>

SOURCE Instrumentation Laboratory
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
2. Mexico and US border attain a new outlook due to BiNational Sustainability Laboratory
3. Laboratory grown vegetarian meat
4. Child specific HIV drugs and laboratory tests should be developed
5. Laboratory Heart valve to study Heart diseases
6. NCFAD Nominated As Reference Laboratory for Bird Flu and BSE
7. British Laboratory Certifies Coke as Safe
8. India to Set Up Nicotine-Mapping Laboratory
9. A Laboratory Filtration System Kills 100 Percent Of Dangerous Microbes In Water
10. Erroneous Laboratory Operation May Lead To a Cancer Drug
11. US Army Opens Laboratory to Research Injuries
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/22/2014)... computational tool developed at the University of Utah (U ... mutations in three separate cases, U of U researchers ... The American Journal of Human Genetics . The ... undiagnosed illnesses and unknown gene mutations by analyzing the ... for genes are made, in individual patients and small ...
(Date:4/22/2014)... cell lung cancer are 70 years of age or ... are not well represented in clinical trials. Therefore, the ... reach evidence based clinical recommendations. , In 2010, the ... Cancer Group along with the International Society for Geriatric ... for elderly patients with non-small cell lung cancer (NSCLC), ...
(Date:4/22/2014)... -- When mothers are exposed to trauma, illness, alcohol ... single molecular trigger in brain cells that can go ... disorder and some forms of autism. , Until now, ... impacted the cells of a developing brain. Past studies ... to alcohol or drug abuse or she experiences some ...
(Date:4/22/2014)... (April 22, 2014) Cedars-Sinai stroke intervention researchers have ... and Stroke, part of the National Institutes of Health, ... multicenter Phase II clinical trial of an experimental drug ... used in combination with recombinant tissue plasminogen activator, or ... ischemic strokes shortly after onset. In laboratory rodent studies, ...
(Date:4/22/2014)... on results of a clinical trial led by ... Drug Administration (FDA) approved a molecularly targeted drug ... has progressed after standard chemotherapy has failed. , ... announced by the manufacturer, Lilly Oncology, of Indianapolis. ... it will be sold under the name Cyramza, ...
Breaking Medicine News(10 mins):Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 2Health News:Applying math to biology: Software identifies disease-causing mutations in undiagnosed illnesses 3Health News:EORTC and SIOG update expert opinion on management of elderly patients with NSCLC 2Health News:Life stressors trigger neurological disorders, researchers find 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 2Health News:$8 million NIH grant will fund multicenter clinical trial of stroke intervention drug 3Health News:FDA approves first targeted drug for advanced stomach cancer 2
... lead character smokes is not as effective a method as ... the appeal of smoking to , are non-smokers. ... the June issue of the journal Tobacco Control. ... whom were current smokers, aged 12-24 years in Australia, over ...
... found that diabetes is associated with decreases in life expectancy, ... ,The study, published in Archives of Internal Medicine, ... with diabetes at age 50 and older appear not to ... without cardiovascular disease, than individuals without diabetes. ,Globalization ...
... Just a short walk from some of Tokyo's most chic ... for long, if the government gets its way . In ... baskets loaded with their fresh catch at Tsukiji market, minutes ... luxury shops and corporate headquarters. The world's largest ...
... disease in monkeys with the help of human stem cell ... in the Proceedings of the National Academy of Sciences, the ... and grew them into large numbers in the laboratory. ... of monkeys with a severe form of chemically induced Parkinson's ...
... ballet shoe are booming in Britain, where the latest unusual ... environment . Since 2000, Vic Fearn and Company have been ... Coffins". The firm recently expanded their range to ... from the clients," said John Gill, head of the Nottingham, ...
... is dumped in Urali Devachi, about 25 kilometers from the ... villagers . ,Urali Devachi village has been turned into ... the citys nearly five million plus population. ,The ... to Urali Devachi, located on Pune-Saswad road, in 1999. ...
Cached Medicine News:Health News:Diabetes Reduces Life Expectancy, Increases Heart Disease Risk 2Health News:Traders Smell Something Fishy in Tokyo Market Move 2Health News:Traders Smell Something Fishy in Tokyo Market Move 3Health News:To Die For: Rolls-Royce and 'green' Coffins at British Funerals 2
(Date:1/15/2014)... 2014  Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ... by its indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), ... of Solta Medical, Inc. (NASDAQ: SLTM ) ...
(Date:1/15/2014)... 2014  Zafgen, Inc., a leading biopharmaceutical company dedicated ... patients, today announced initial results from its Phase ... methionine aminopeptidase 2 (MetAP2), in patients with Prader-Willi ...  These results showed improvements in body weight, hunger-related ...
(Date:1/14/2014)... AUSTIN, Texas , Jan. 14, 2014  Luminex Corporation (Nasdaq: ... report results for the fourth quarter of 2013 on Monday, ... scheduled for release after the close of trading. ... a conference call to discuss the operating highlights and financial ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 2Luminex Corporation Fourth Quarter Earnings Release Scheduled for February 3, 2014 3
... 2011 Phreesia, the patient check-in company, today ... health records (EHR) software and solutions, has been ... partnership, medical practices nationwide that use both SOAPware ... seamless patient check-in experience. The automated interface between ...
... 18, 2011 Ohio-based AdCare Health Systems, Inc. ... Remedi SeniorCare®, one of the nation,s largest institutional ... services for AdCare,s facilities  that deliver long-term care ... Remedi pharmacy services will include pharmacist ...
Cached Medicine Technology:Phreesia and SOAPware Integrate to Improve Clinical Data and Streamline Workflow at Medical Practices 2Phreesia and SOAPware Integrate to Improve Clinical Data and Streamline Workflow at Medical Practices 3AdCare Health Systems Selects Remedi SeniorCare for Long-Term Care Pharmacy Solutions 2AdCare Health Systems Selects Remedi SeniorCare for Long-Term Care Pharmacy Solutions 3
Inquire...
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
Use the Mo Bio Vortex adapter to process multiple samples at the same time. The adapter holds tubes horizontally to increase cell lysis and mixing efficiency. Ideal for bead beating procedures....
... Mo Bio Vortex Adapter in conjunction with the ... Using the Mo Bio Vortex Adapter is ... Fast Prep machines which offer the same technology. ... centrifuge tubes at one time and will fit ...
Medicine Products: